Home Newsfeeds ProMIS Neurosciences Q3 EPS $(0.85) Down From $(0.20) YoY

ProMIS Neurosciences Q3 EPS $(0.85) Down From $(0.20) YoY

ProMIS Neurosciences (NASDAQ:PMN) reported quarterly losses of $(0.85) per share. This is a 325 percent decrease over losses of $(0.20) per share from the same period last year.

byBenzinga Newsdesk

November 14, 2022

1 minute read

ProMIS Neurosciences (NASDAQ:PMN) reported quarterly losses of $(0.85) per share. This is a 325 percent decrease over losses of $(0.20) per share from the same period last year.

Terreno Realty Corporation Increases Quarterly Dividend From $0.40 To $0.45/Share

By Happy Mohamed

August 2, 5:29 PM

Terreno Realty Corporation (NYSE:TRNO), an acquirer, owner and operator of industrial real estate in six major coastal U.S. markets, declared a regular cash dividend for the quarter ending September 30, 2023

TRNO

Tupperware Shares Are Trading Higher Tuesday: What’s Going On?

By Adam Eckert

October 17, 10:40 AM

Tupperware Brands Corp (NYSE: TUP) shares are trading higher. The company on Tuesday announced a CEO transition and board refresh.

TUP

PharmaCyte Biotech Makes $7M Investment In MyMD Pharmaceuticals; Investment In Life Sciences Solidifies Previously Announced Strategy To Utilize Significant Cash Position To Create Additional Stockholder Value

By Benzinga Newsdesk

May 21, 9:41 AM

Second external investment in life sciences solidifies previously announced strategy to utilize significant cash position to create additional stockholder valuePharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the

MYMD